Robert Fahrner BA

Rob Fahrner is a Senior Principal Scientist and Group Leader in Purification Process Development, Bioprocess R&D at Pfizer. He has 28 years of experience in the biopharmaceutical industry, including five years at Pfizer and sixteen years at Genentech. Rob has worked on commercializing several mAb products, and developed Rituxan and Herceptin from Phase II through commercialization and post-BLA process improvements.

He has published extensively on developing a mAb platform process, significant improvements in Protein A chromatography, understanding membrane separations and modes of chromatography, and alternatives to chromatography processes. He has led teams responsible for end-to-end development, from cell line to GMP manufacturing, and he is currently part of the Next Generation Manufacturing project in collaboration with Boehringer Ingelheim.